Literature DB >> 20504833

Association between anti-beta2 glycoprotein I antibodies and renal glomerular C4d deposition in lupus nephritis patients with glomerular microthrombosis: a prospective study of 155 cases.

Y Shen1, X-W Chen, C-Y Sun, M Dai, Y-C Yan, C-D Yang.   

Abstract

Glomerular microthrombosis (GMT) is a common vascular change in patients with lupus nephritis (LN). The mechanism underlying GMT is still unknown. In our previous study, we found that the level of IgG anti-beta2 glycoprotein I (beta2GPI) antibodies was higher in the LN-GMT group than in the LN-non-GMT group, which indicated that anti-beta2GPI antibodies may play a role in GMT formation. Many studies have demonstrated that the activation of the classical complement pathway may play a critical role in fetal loss and aPL-induced thrombosis formation. To investigate whether complement activation plays a role in GMT formation and to evaluate its relationship with aPL, we prospectively investigated deposition of C4d in 155 renal biopsy specimens of LN patients. The results revealed a strong relationship between the intensity of glomerular C4d staining and the presence of microthrombi (p < 0.001). The detection rate of IgG anti-beta2GPI antibodies was higher in the LN-GMT group than in the LN-non-GMT group (p < 0.05). Further, the intensity of glomerular C4d staining was significantly related with IgG anti-beta2GPI antibodies (p < 0.05). The results of our study suggest that anti-beta2GPI antibodies may play a role in GMT formation, and this process might involve complement activation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20504833     DOI: 10.1177/0961203310368409

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  14 in total

1.  A high-risk laboratory profile of antiphospholipid antibodies and thrombosis is associated with a large number of extra-criteria manifestations in obstetric antiphospholipid syndrome.

Authors:  Sebastián Udry; José Omar Latino; Cristina Belizna; Silvia Perés Wingeyer; Diego Santiago Fernández Romero; Gabriela de Larrañaga
Journal:  Immunol Res       Date:  2019-12       Impact factor: 2.829

Review 2.  Pros and cons for C4d as a biomarker.

Authors:  Danielle Cohen; Robert B Colvin; Mohamed R Daha; Cinthia B Drachenberg; Mark Haas; Volker Nickeleit; Jane E Salmon; Banu Sis; Ming-Hui Zhao; Jan A Bruijn; Ingeborg M Bajema
Journal:  Kidney Int       Date:  2012-02-01       Impact factor: 10.612

3.  Complement Factor C4d Is a Common Denominator in Thrombotic Microangiopathy.

Authors:  Jamie S Chua; Hans J Baelde; Malu Zandbergen; Suzanne Wilhelmus; Leendert A van Es; Johan W de Fijter; Jan A Bruijn; Ingeborg M Bajema; Danielle Cohen
Journal:  J Am Soc Nephrol       Date:  2015-01-08       Impact factor: 10.121

4.  Renal arteriolar C4d deposition: a novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

Authors:  Benjamin L Laskin; Julia Maisel; Jens Goebel; Hong J Yin; Guangju Luo; Jane C Khoury; Stella M Davies; Sonata Jodele
Journal:  Transplantation       Date:  2013-07-27       Impact factor: 4.939

5.  Clinicopathologic correlations of renal microthrombosis and inflammatory markers in proliferative lupus nephritis.

Authors:  Elena Gonzalo; Oscar Toldos; María P Martínez-Vidal; María C Ordoñez; Begoña Santiago; Antonio Fernández-Nebro; Estíbaliz Loza; Isabel García; Myriam León; José L Pablos; María Galindo
Journal:  Arthritis Res Ther       Date:  2012-05-28       Impact factor: 5.156

Review 6.  Extra-renal manifestations of complement-mediated thrombotic microangiopathies.

Authors:  Johannes Hofer; Alejandra Rosales; Caroline Fischer; Thomas Giner
Journal:  Front Pediatr       Date:  2014-09-08       Impact factor: 3.418

7.  Complement activation and effect of eculizumab in scleroderma renal crisis.

Authors:  Arnaud Devresse; Selda Aydin; Moglie Le Quintrec; Nathalie Demoulin; Patrick Stordeur; Catherine Lambert; Sara Gastoldi; Yves Pirson; Michel Jadoul; Johann Morelle
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

8.  Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis.

Authors:  Juan M Mejia-Vilet; Ismael A Gómez-Ruiz; Cristino Cruz; R Angélica Méndez-Pérez; Roque A Comunidad-Bonilla; Norma O Uribe-Uribe; Carlos A Nuñez-Alvarez; Luis E Morales-Buenrostro
Journal:  Clin Rheumatol       Date:  2020-11-10       Impact factor: 2.980

9.  The Spectrum of C4d Deposition in Renal Biopsies of Lupus Nephritis Patients.

Authors:  Ying Ding; Xiaojuan Yu; Lihua Wu; Ying Tan; Zhen Qu; Feng Yu
Journal:  Front Immunol       Date:  2021-07-01       Impact factor: 7.561

10.  The spectrum of renal thrombotic microangiopathy in lupus nephritis.

Authors:  Di Song; Li-hua Wu; Feng-mei Wang; Xiao-wei Yang; Di Zhu; Min Chen; Feng Yu; Gang Liu; Ming-hui Zhao
Journal:  Arthritis Res Ther       Date:  2013-01-15       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.